# QUVIVIQ
> **NDA214985** · New Drug Application · Sponsor: IDORSIA · Approved 2022-01-07
## Drug
- **FDA Application Number:** NDA214985
- **Application type:** New Drug Application
- **Brand name:** QUVIVIQ
- **Generic name:** DARIDOREXANT
- **Active ingredients:** DARIDOREXANT HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IDORSIA
- **Manufacturer:** Idorsia Pharmaceuticals Ltd
- **First approval:** 2022-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214985)
---
*MORVS · CC0 1.0*